Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting. | Clin Adv Hematol Oncol;2(5): 284-9, 2004 May. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Palonosetron: a unique 5-HT3 receptor antagonist indicated for the prevention of acute and delayed chemotherapy-induced nausea and vomiting.

Rubenstein, Edward B.

Affiliation

Rubenstein EB; MGI Pharma, Inc., Bloomington, MN 55437, USA. ed.rubenstein@mgipharma.com

Clin Adv Hematol Oncol ; 2(5): 284-9, 2004 May.

Article in En | MEDLINE | ID: mdl-16163194

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Quinuclidines / Vomiting / Isoquinolines / Antiemetics / Nausea / Antineoplastic Agents Language: En Journal: Clin Adv Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2004 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Quinuclidines / Vomiting / Isoquinolines / Antiemetics / Nausea / Antineoplastic Agents Language: En Journal: Clin Adv Hematol Oncol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2004 Document type: Article Affiliation country: Country of publication: